Population vulnerability to COVID-19 in Europe: a burden of disease analysis

Abstract Background Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health consequences from COVID-19. In Europe, this is of particular relevance with ageing populations living with non-communicable dis...

Full description

Bibliographic Details
Main Authors: Grant M. A. Wyper, Ricardo Assunção, Sarah Cuschieri, Brecht Devleeschauwer, Eilidh Fletcher, Juanita A. Haagsma, Henk B. M. Hilderink, Jane Idavain, Tina Lesnik, Elena Von der Lippe, Marek Majdan, Milena S. Milicevic, Elena Pallari, José L. Peñalvo, Sara M. Pires, Dietrich Plaß, João V. Santos, Diane L. Stockton, Sofie Theresa Thomsen, Ian Grant
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Archives of Public Health
Subjects:
YLD
Online Access:http://link.springer.com/article/10.1186/s13690-020-00433-y
id doaj-9b8099169b444dcbada1f6de3a744dcc
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Grant M. A. Wyper
Ricardo Assunção
Sarah Cuschieri
Brecht Devleeschauwer
Eilidh Fletcher
Juanita A. Haagsma
Henk B. M. Hilderink
Jane Idavain
Tina Lesnik
Elena Von der Lippe
Marek Majdan
Milena S. Milicevic
Elena Pallari
José L. Peñalvo
Sara M. Pires
Dietrich Plaß
João V. Santos
Diane L. Stockton
Sofie Theresa Thomsen
Ian Grant
spellingShingle Grant M. A. Wyper
Ricardo Assunção
Sarah Cuschieri
Brecht Devleeschauwer
Eilidh Fletcher
Juanita A. Haagsma
Henk B. M. Hilderink
Jane Idavain
Tina Lesnik
Elena Von der Lippe
Marek Majdan
Milena S. Milicevic
Elena Pallari
José L. Peñalvo
Sara M. Pires
Dietrich Plaß
João V. Santos
Diane L. Stockton
Sofie Theresa Thomsen
Ian Grant
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Archives of Public Health
COVID-19
Coronavirus
Burden of disease
DALY
YLD
Summary measures of population health
author_facet Grant M. A. Wyper
Ricardo Assunção
Sarah Cuschieri
Brecht Devleeschauwer
Eilidh Fletcher
Juanita A. Haagsma
Henk B. M. Hilderink
Jane Idavain
Tina Lesnik
Elena Von der Lippe
Marek Majdan
Milena S. Milicevic
Elena Pallari
José L. Peñalvo
Sara M. Pires
Dietrich Plaß
João V. Santos
Diane L. Stockton
Sofie Theresa Thomsen
Ian Grant
author_sort Grant M. A. Wyper
title Population vulnerability to COVID-19 in Europe: a burden of disease analysis
title_short Population vulnerability to COVID-19 in Europe: a burden of disease analysis
title_full Population vulnerability to COVID-19 in Europe: a burden of disease analysis
title_fullStr Population vulnerability to COVID-19 in Europe: a burden of disease analysis
title_full_unstemmed Population vulnerability to COVID-19 in Europe: a burden of disease analysis
title_sort population vulnerability to covid-19 in europe: a burden of disease analysis
publisher BMC
series Archives of Public Health
issn 2049-3258
publishDate 2020-05-01
description Abstract Background Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health consequences from COVID-19. In Europe, this is of particular relevance with ageing populations living with non-communicable diseases, multi-morbidity and frailty. Published estimates of Years Lived with Disability (YLD) from the Global Burden of Disease (GBD) study help to characterise the extent of these effects. Our aim was to identify the countries across Europe that have populations at highest risk from COVID-19 by using estimates of population age structure and YLD for health conditions linked to severe illness from COVID-19. Methods Population and YLD estimates from GBD 2017 were extracted for 45 countries in Europe. YLD was restricted to a list of specific health conditions associated with being at risk of developing severe consequences from COVID-19 based on guidance from the United Kingdom Government. This guidance also identified individuals aged 70 years and above as being at higher risk of developing severe health consequences. Study outcomes were defined as: (i) proportion of population aged 70 years and above; and (ii) rate of YLD for COVID-19 vulnerable health conditions across all ages. Bivariate groupings were established for each outcome and combined to establish overall population-level vulnerability. Results Countries with the highest proportions of elderly residents were Italy, Greece, Germany, Portugal and Finland. When assessments of population-level YLD rates for COVID-19 vulnerable health conditions were made, the highest rates were observed for Bulgaria, Czechia, Croatia, Hungary and Bosnia and Herzegovina. A bivariate analysis indicated that the countries at high-risk across both measures of vulnerability were: Bulgaria; Portugal; Latvia; Lithuania; Greece; Germany; Estonia; and Sweden. Conclusion Routine estimates of population structures and non-fatal burden of disease measures can be usefully combined to create composite indicators of vulnerability for rapid assessments, in this case to severe health consequences from COVID-19. Countries with available results for sub-national regions within their country, or national burden of disease studies that also use sub-national levels for burden quantifications, should consider using non-fatal burden of disease estimates to estimate geographical vulnerability to COVID-19.
topic COVID-19
Coronavirus
Burden of disease
DALY
YLD
Summary measures of population health
url http://link.springer.com/article/10.1186/s13690-020-00433-y
work_keys_str_mv AT grantmawyper populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT ricardoassuncao populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT sarahcuschieri populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT brechtdevleeschauwer populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT eilidhfletcher populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT juanitaahaagsma populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT henkbmhilderink populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT janeidavain populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT tinalesnik populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT elenavonderlippe populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT marekmajdan populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT milenasmilicevic populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT elenapallari populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT joselpenalvo populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT sarampires populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT dietrichplaß populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT joaovsantos populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT dianelstockton populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT sofietheresathomsen populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
AT iangrant populationvulnerabilitytocovid19ineuropeaburdenofdiseaseanalysis
_version_ 1724656332148047872
spelling doaj-9b8099169b444dcbada1f6de3a744dcc2020-11-25T03:10:56ZengBMCArchives of Public Health2049-32582020-05-017811810.1186/s13690-020-00433-yPopulation vulnerability to COVID-19 in Europe: a burden of disease analysisGrant M. A. Wyper0Ricardo Assunção1Sarah Cuschieri2Brecht Devleeschauwer3Eilidh Fletcher4Juanita A. Haagsma5Henk B. M. Hilderink6Jane Idavain7Tina Lesnik8Elena Von der Lippe9Marek Majdan10Milena S. Milicevic11Elena Pallari12José L. Peñalvo13Sara M. Pires14Dietrich Plaß15João V. Santos16Diane L. Stockton17Sofie Theresa Thomsen18Ian Grant19Place and Wellbeing Directorate, Public Health ScotlandFood and Nutrition Department, National Institute of Health Dr. Ricardo JorgeDepartment of Anatomy, Faculty of Medicine and Surgery, University of MaltaDepartment of Epidemiology and Public Health, SciensanoData Driven Innovation Directorate, Public Health ScotlandDepartment of Public Health, Erasmus MC University Medical CenterNational Institute for Public Health and the Environment (RIVM)National Institute for Health DevelopmentNational Institute of Public HealthDepartment of Epidemiology and Health Monitoring, Robert Koch InstituteDepartment of Public Health, Institute for Global Health and Epidemiology, Faculty of Health Sciences and Social Work, Trnava UniversityFaculty of Medicine University of BelgradeMRC Clinical Trials and Methodology Unit, University College LondonUnit of Noncommunicable Diseases, Department of Public Health, Institute of Tropical MedicineNational Food Institute, Technical University of DenmarkExposure Assessment and Environmental Health Indicators, German Environment AgencyMEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of PortoPlace and Wellbeing Directorate, Public Health ScotlandNational Food Institute, Technical University of DenmarkData Driven Innovation Directorate, Public Health ScotlandAbstract Background Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health consequences from COVID-19. In Europe, this is of particular relevance with ageing populations living with non-communicable diseases, multi-morbidity and frailty. Published estimates of Years Lived with Disability (YLD) from the Global Burden of Disease (GBD) study help to characterise the extent of these effects. Our aim was to identify the countries across Europe that have populations at highest risk from COVID-19 by using estimates of population age structure and YLD for health conditions linked to severe illness from COVID-19. Methods Population and YLD estimates from GBD 2017 were extracted for 45 countries in Europe. YLD was restricted to a list of specific health conditions associated with being at risk of developing severe consequences from COVID-19 based on guidance from the United Kingdom Government. This guidance also identified individuals aged 70 years and above as being at higher risk of developing severe health consequences. Study outcomes were defined as: (i) proportion of population aged 70 years and above; and (ii) rate of YLD for COVID-19 vulnerable health conditions across all ages. Bivariate groupings were established for each outcome and combined to establish overall population-level vulnerability. Results Countries with the highest proportions of elderly residents were Italy, Greece, Germany, Portugal and Finland. When assessments of population-level YLD rates for COVID-19 vulnerable health conditions were made, the highest rates were observed for Bulgaria, Czechia, Croatia, Hungary and Bosnia and Herzegovina. A bivariate analysis indicated that the countries at high-risk across both measures of vulnerability were: Bulgaria; Portugal; Latvia; Lithuania; Greece; Germany; Estonia; and Sweden. Conclusion Routine estimates of population structures and non-fatal burden of disease measures can be usefully combined to create composite indicators of vulnerability for rapid assessments, in this case to severe health consequences from COVID-19. Countries with available results for sub-national regions within their country, or national burden of disease studies that also use sub-national levels for burden quantifications, should consider using non-fatal burden of disease estimates to estimate geographical vulnerability to COVID-19.http://link.springer.com/article/10.1186/s13690-020-00433-yCOVID-19CoronavirusBurden of diseaseDALYYLDSummary measures of population health